» Authors » V Mohamed-Ali

V Mohamed-Ali

Explore the profile of V Mohamed-Ali including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 58
Citations 2824
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Athanasiadou I, Kraiem S, Al-Sowaidi S, Al-Mohammed H, Dbes N, Al-Yazedi S, et al.
Drug Test Anal . 2018 May; 10(9):1458-1468. PMID: 29745045
The urinary 'steroid profile' in doping control analysis is a powerful tool aimed at detecting intra-individual deviations related to the abuse of endogenous steroids. Factors altering the steroid profile include,...
2.
Alsaadi K, Voss S, Kraiem S, Alwahaibi A, Alyazedi S, Dbes N, et al.
Drug Test Anal . 2015 Dec; 7(11-12):1017-24. PMID: 26695489
This study investigated the effect of Ramadan on the haematological and steroid module of the Athletes Biological Passport (ABP) of the World Anti-Doping Agency (WADA). Nine healthy physically active subjects...
3.
Flachs P, Ruhl R, Hensler M, Janovska P, Zouhar P, Kus V, et al.
Diabetologia . 2011 Jul; 54(10):2626-38. PMID: 21779874
Aims/hypothesis: Calorie restriction is an essential component in the treatment of obesity and associated diseases. Long-chain n-3 polyunsaturated fatty acids (LC n-3 PUFA) act as natural hypolipidaemics, reduce the risk...
4.
Kuda O, Jelenik T, Jilkova Z, Flachs P, Rossmeisl M, Hensler M, et al.
Diabetologia . 2009 Mar; 52(5):941-51. PMID: 19277604
Aims/hypothesis: Fatty acids of marine origin, i.e. docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) act as hypolipidaemics, but they do not improve glycaemic control in obese and diabetic patients. Thiazolidinediones...
5.
Ogston N, Karastergiou K, Hosseinzadeh-Attar M, Bhome R, Madani R, Stables M, et al.
Int J Obes (Lond) . 2008 Nov; 32(12):1807-15. PMID: 18982014
Background: Chronically elevated interleukin-6 (IL-6) is implicated in obesity-associated pathologies, where a proportion of this cytokine is derived from adipose tissue. Proinflammatory prostaglandins, which regulate this cytokine elsewhere, are also...
6.
Britton M, Denver A, Mohamed-Ali V, Yudkin J
Clin Drug Investig . 2008 Mar; 16(4):303-17. PMID: 18370552
Objective: This study aimed to compare the effects of glimepiride and glibenclamide on glycaemic control and a range of risk factors for ischaemic heart disease (IHD), including concentrations of insulin-like...
7.
Flachs P, Mohamed-Ali V, Horakova O, Rossmeisl M, Hosseinzadeh-Attar M, Hensler M, et al.
Diabetologia . 2006 Jan; 49(2):394-7. PMID: 16397791
Aims/hypothesis: Diets rich in n-3 polyunsaturated fatty acids, namely eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), protect against insulin resistance and obesity in rodents and increase insulin sensitivity in healthy...
8.
DAiuto F, Nibali L, Mohamed-Ali V, Vallance P, Tonetti M
J Periodontal Res . 2004 Aug; 39(5):294-9. PMID: 15324349
Background: Chronic periodontitis causes a low-grade systemic inflammatory response; its standard treatment, however, induces an acute inflammatory response. The aim of this study was to describe the systemic inflammatory reactions...
9.
Yudkin J, Juhan-Vague I, Hawe E, Humphries S, Di Minno G, Margaglione M, et al.
Metabolism . 2004 Jul; 53(7):852-7. PMID: 15254876
Risk of coronary heart disease has been related to insulin resistance, but the mechanism for this is incompletely understood. Variables attributed to insulin resistance are associated with low-grade inflammation. A...
10.
Brydon L, Edwards S, Mohamed-Ali V, Steptoe A
Brain Behav Immun . 2004 Mar; 18(3):281-90. PMID: 15050655
Coronary artery disease (CAD) is more prevalent in people from a low socioeconomic background, and low socioeconomic status (SES) is associated with an increased exposure to psychological stress. The pro-inflammatory...